Matches in Nanopublications for { ?s ?p "[Seventy-two patients with non-Hodgkin's lymphoma were evaluated for the presence of molecular markers (IgH, bcl-1, bcl-2 rearrangement) on bone marrow, at diagnosis and after PBSCT, and on harvests in order to find a possible predictive role of minimal residual disease on treatment outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Seventy-two patients with non-Hodgkin's lymphoma were evaluated for the presence of molecular markers (IgH, bcl-1, bcl-2 rearrangement) on bone marrow, at diagnosis and after PBSCT, and on harvests in order to find a possible predictive role of minimal residual disease on treatment outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP260937.RACoABduUnwnq8WBIjn9rqVzAg_z97O64jA57MqBV3gfQ130_assertion description "[Seventy-two patients with non-Hodgkin's lymphoma were evaluated for the presence of molecular markers (IgH, bcl-1, bcl-2 rearrangement) on bone marrow, at diagnosis and after PBSCT, and on harvests in order to find a possible predictive role of minimal residual disease on treatment outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260937.RACoABduUnwnq8WBIjn9rqVzAg_z97O64jA57MqBV3gfQ130_provenance.
- NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_assertion description "[Seventy-two patients with non-Hodgkin's lymphoma were evaluated for the presence of molecular markers (IgH, bcl-1, bcl-2 rearrangement) on bone marrow, at diagnosis and after PBSCT, and on harvests in order to find a possible predictive role of minimal residual disease on treatment outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263116.RASyEZnsw-0E8pKw_CEVYuSt5IN3hvNYUO9cyjUv-93YY130_provenance.
- assertion description "[Seventy-two patients with non-Hodgkin's lymphoma were evaluated for the presence of molecular markers (IgH, bcl-1, bcl-2 rearrangement) on bone marrow, at diagnosis and after PBSCT, and on harvests in order to find a possible predictive role of minimal residual disease on treatment outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP353133.RAzWx7NKzzgPmpRn57Tywb872UJl07J6eCQf4YReK_m7g130_assertion description "[Seventy-two patients with non-Hodgkin's lymphoma were evaluated for the presence of molecular markers (IgH, bcl-1, bcl-2 rearrangement) on bone marrow, at diagnosis and after PBSCT, and on harvests in order to find a possible predictive role of minimal residual disease on treatment outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353133.RAzWx7NKzzgPmpRn57Tywb872UJl07J6eCQf4YReK_m7g130_provenance.
- NP353135.RA5AyQHjimyUn0r7ql1E85hIjd2agaecJuX7al0WQb8Gk130_assertion description "[Seventy-two patients with non-Hodgkin's lymphoma were evaluated for the presence of molecular markers (IgH, bcl-1, bcl-2 rearrangement) on bone marrow, at diagnosis and after PBSCT, and on harvests in order to find a possible predictive role of minimal residual disease on treatment outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353135.RA5AyQHjimyUn0r7ql1E85hIjd2agaecJuX7al0WQb8Gk130_provenance.